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Background. Phospholipase C (PLC) is an important factor in
signal transduction because this enzyme is activated by several
hormones and growth factors. Eight PLC isoforms have been
described raising the possibility that different cells express a single
isoform or activate specific isoforms in different cells. Therefore,
the goal of this study was to determine which PLC isoforms are
expressed in specific regions of rat kidney.
Methods. Western blot analysis was performed in microdis-
sected nephron segments of rat kidney, while immunohistochem-
ical analysis was performed on whole rat kidney slices using PLC
isoform-specific antibodies.
Results. All three families of PLC isoforms (b, g, and d) were
present throughout the cortical and medullary regions of the
kidney. Only the PLC-b1 isoform was observed in the brush
border of the proximal tubule, but all isoforms were present in
glomeruli and in the cytoplasm of tubular epithelial cells. In
addition, only the PLC-g1 isoform was expressed in the internal
elastic lamina of the renal artery, while vasa recta expressed
PLC-b1 most intensely. Medullary thick ascending limbs showed
an intense level of expression of all three isoforms.
Conclusion. Multiple PLC isoforms are present in glomeruli,
renal tubules, and renal vasculature in vivo, but with some
segment-specific differences. These findings suggest that the
response of a specific cell is not determined by expression of only
one PLC isoform, with the exception of the brush border of the
proximal tubule and the renal arteries. Instead, the presence of
multiple PLC isoforms in specific regions of the kidney suggests
that hormonal regulation in vivo involves mechanisms beyond
cell-specific isoforms of PLC.
Phospholipase C (PLC) is an important signal transduc-
tion enzyme that is activated by several hormones and
growth factors that also regulate kidney function. Due to
the difficulties in studying signal transduction pathways in
kidney tissue, cell culture models have generally been used
to elucidate signaling pathways. For example, in cultured
glomerular mesangial cells and cultured vascular smooth
muscle cells, the binding of angiotensin II and platelet-
derived growth factor to their cell surface receptors results
in the activation of an inositol phospholipid-specific PLC
[1–3]. PLC catalyzes the hydrolysis of phosphatidyl-inositol
4,5-biphosphate to form two second-messenger molecules:
diacylglycerol (DAG) and inositol 1,4,5-triphosphate
(1,4,5-IP3) [4]. These second messengers activate protein
kinase C (PKC) and promote the release of calcium from
intracellular stores, respectively [5, 6]. An increase in
cytosolic calcium leads to vasoconstriction while PKC acti-
vation leads to a cascade of protein phosphorylations that
are thought to regulate aspects of proximal tubule function,
including the regulation of sodium transport [7].
PLC isoforms are present in most mammalian tissues but
are expressed at different levels in various cells. Mamma-
lian PLCs can be divided into three families (PLC-b,
PLC-g, and PLC-d), each of which is a discrete gene
product and is found in both the cell membrane and
cytoplasm [8]. All PLC isoforms contain unique amino acid
sequences and there are specific antibodies to each of the
isoforms. The molecular weights of the known isoforms are:
150 to 154 kD for PLC-b1, -b2, -b3, and -b4 [9]; 145 to 148
kD for PLC-g1 and g2 [9]; and 85 to 88 kD for PLC-d1 and
-d2 [10].
Because of the multiplicity of PLC isoforms, it is possible
that specific PLC isoforms mediate different intracellular
signaling pathways in different nephron segments or that
nephron segments expressing multiple PLC isoforms could
be regulated by several hormones, depending upon which
PLC isoform is activated. Currently, there is little informa-
tion concerning which PLC isoforms are present in specific
structures within the kidney. The goal of the present study
was to determine the expression of the PLC isoforms in
specific structures within normal rat kidney as a first step
towards understanding the roles of individual PLC isoforms
in signal transduction events that affect renal function.
METHODS
Tissue preparation
Pathogen-free, male, Sprague-Dawley rats (75 to 100 g)
were anesthetized with Nembutal (2 mg/kg body wt i.p.;
Abbott Laboratories, Chicago, IL, USA). The left kidney
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Fig. 1. Expression of phospholipase C (PLC)-
b1 in microdissected rat proximal convoluted
tubule (PCT) and glomeruli. Western blot
analysis of protein from rat PCT and glomeruli
(100 mg protein loaded) identifies a 150 kD
protein when probed with an affinity-purified
polyclonal rabbit anti-rat antibody to PLC-b1.
In CCDs and mTALs (20 mg protein loaded),
protein was also detected with the PLC-b1
monoclonal antibody (results not shown).
Fig. 2. Phospholipase C (PLC)-b1 in rat kidney. A, B, C and E represent
the cortex, and D represents the inner stripe of outer medulla. Strong
proximal tubule brush border (p) positivity is seen in panels A and B.
Glomerular epithelial cells and capillary loops (panel C), and distal
convoluted tubule (d) epithelial cell cytoplasms (panels A and C) reveal
weak (11), whereas mTALs (m) show moderate (21) immunoreactivity
(panel D). Collecting tubules (c) as seen in a medullary ray in (panel A)
and inner stripe of outer medulla in panel D exhibit intense expression.
Arterioles (a) are negative (panel A) in contrast to widespread vasa recta
(v) positivity in panel D. Panel E is negative control where primary
antibody was substituted with PBS (immunohistochemistry, 1:250 rabbit
anti-rat polyclonal PLC-b1 antibody, A 3200, B 3400, C 3600, D 3400;
E, Immunohistochemistry, negative control, 3200). Publication of this
figure in color was made possible by a grant from Hoechst Marion
Roussel, Inc.
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was perfused with ice-cold dissection solution containing 1
mg/ml of collagenase (Type A; Boehringer Mannheim,
Indianapolis, IN, USA) and bovine serum albumin (Sigma
Chemical Co., St. Louis, MO, USA) and cut into cortical
and outer medullary slices that were incubated at 37°C in a
collagenase solution as described [11]. The composition of
the dissection solution in (mM) was: NaCl 137; KCl 5;
MgSO4 0.8; Na2HPO4 0.33; KH2PO4 0.44; MgCl2 1; Tris-
HCl 10; and CaCl2 0.25. The following nephron segments
were microdissected: S2 subsegments of the proximal con-
voluted tubule (PCT), cortical collecting ducts (CCDs), and
medullary thick ascending limbs (mTALs). These segments
were manually dissected under direct microscopic vision
and thus were a pure population of cells. Intact glomeruli
were prepared by mincing cortex into cubes and pushing
them through a 150 mm stainless steel sieve. The material
was then resuspended in phosphate buffered saline (PBS)
and passed through a 70 to 80 mm nylon mesh [12]. The
glomeruli retained on the mesh were rinsed off with PBS.
The purity of the glomeruler suspension was confirmed by
light microscopy.
Phospholipase C primary antibodies
The primary antibodies used were affinity-purified, anti-
PLC isoform-specific rabbit polyclonal antibodies (Santa
Cruz Biotechnology, Santa Cruz, CA, USA) raised against
the rat b1, g1, and d1 PLC isoforms (1 mg/ml). These
antibodies react specifically against PLC isoforms of
mouse, rat, or human origin but do not cross-react with
other PLC isozymes. Monoclonal antibodies developed in
mouse and raised against bovine PLC-b1 (5 mg/ml),
PLC-g1 (0.5 mg/ml), and PLC-d1 (1 mg/ml) subunits (Up-
state Biotechnology Incorporated, Lake Placid, NY, USA)
were also used and have been shown to recognize the rat,
mouse, and human forms of each specific isozyme class.
Western blot analysis
The sieved glomeruli and the microdissected nephron
segments were suspended in our “High Test” buffer con-
taining proteinase inhibitors: 0.125 M Tris-HCl; 20% glyc-
erol (by vol); 6% SDS (by wt); 10 mg/ml leupeptin; 5 mg/ml
chymostatin; 10 mg/ml aprotinin; 50 mM benzamidine; 10
mg/ml PMSF; 10 mg/ml pepstatin; and 5 mg/ml sodium
trypsin inhibitor. Protein content was measured spectro-
photometrically (Pierce Immunotechnology, Rockford, IL,
USA). Proteins from nephron segments were size-sepa-
rated by sodium dodecyl sulfate (SDS)-polyacrylamide gel
(7.5%) electrophoresis. Proteins from rat brain and liver
were used as positive controls.
Following separation, proteins were transferred to 0.45
mm nitrocellulose membranes (Life Technologies, Gaith-
ersburg, MD, USA) by electroblotting [13] and incubated
overnight with blocking buffer (TTBS-NFM). The compo-
sition of (TTBS-NFM) was: Tris-buffered saline (TBS), 20
mM; Tris-HCl, 0.5 M; NaCl, pH 7.5; Tween-20 (5% vol/vol);
and non-fat dried milk (5% wt/vol). Excessive blocking
buffer was removed and blots washed for 15 minutes with
TBS for a minimum of two washes.
Blots were incubated with the monoclonal antibodies
overnight while those probed with the polyclonal antibodies
were incubated for two hours. After three 15-minute
washes with TBS, blots were incubated with an alkaline
phosphatase conjugated secondary antibody, which was
either goat, anti-mouse IgG or goat, anti-rabbit IgG at
1:2000 (Amersham, Arlington Heights, IL, USA) for the
primary monoclonal or polyclonal antibodies, respectively.
Excess secondary antibody was removed by washing with
TBS before chemiluminescence was analyzed according to
the manufacturer’s protocol (ECL Western Blot Kit; Am-
ersham) [14].
Immunohistochemical analysis
An avidin-biotin complex-alkaline phosphatase kit (Vec-
tastain ABC-AP Kit; Vector Laboratories, Burlingame,
CA, USA) was used for the immunohistochemical study.
Fresh rat kidney was fixed in 10% buffered formalin for 24
hours, exposed to routine light microscopy processing, and
embedded into paraffin. Tissue sections (5 mm) were
deparaffinized in xylene and rehydrated in a graded series
of ethanol. Microwave treatment was applied for antigen
retrieval in 0.1 M Tris-HCl, pH 9.5 buffer containing 5%
urea for 10 minutes. The sections were exposed to blocking
antibody for 20 minutes and incubated with an appropriate
primary antibody overnight at room temperature in a
humid chamber. Optimal antibody concentrations for each
of the two (b1 and g1) polyclonal and one (d1) monoclonal
PLC isoform specific antibodies were determined by titra-
tion. These concentrations were: 1/250 for anti-PLC-b1;
Table 1. Phospholipase C (PLC) isoform expression in rat kidney
b1 g1 d1
Cortex
Glomeruli present present present
PCT present present present
BBMa present absent absent
CCD present present present
DCTa present present present
Medulla
S3 desc. limba present present present
BBMa present absent absent
mTAL present present present
OMCDa present present present
IMCDa present present present
Vasculature
Arteriesa absent present absent
Vasa rectaa present present present
Abbreviations are: PCT, proximal convoluted tubule; BBM, brush
border membrane; CCD, cortical collecting duct; DCT, distal convoluted
tubule; mTAL, medullary thick ascending limb; OMCD, outer medullary
collecting duct; IMCD, inner medullary collecting duct.
a Only examined by immunohistochemistry; all others are by Western
blot & immunohistochemistry
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1/100 for anti-PLC-g1; and 1/100 for anti-PLC-d1. Sections
were then washed three times with PBS and treated with a
secondary, biotinylated antibody for 30 minutes in the
concentration recommended by the manufacturer for anti-
rabbit, and in 5 mg/ml for anti-mouse secondary antibodies.
Following washes with PBS, the sections were reacted with
the avidin-biotinylated alkaline phosphatase enzyme com-
plex for 30 minutes and after rinsing twice in PBS, incu-
bated for 30 minutes in substrate solution which also
contained levamisole to inhibit endogenous alkaline phos-
phatase activity. The slides were washed with distilled
water, counterstained with hematoxylin and mounted. The
primary antibody was replaced by buffer in negative control
studies.
Evaluation of the immunostaining
Sections prepared for immunohistochemical examina-
tion were evaluated for the presence, intensity, and local-
ization of each PLC isoenzyme. Specific staining was semi-
quantitated by assigning a score of 0 to 3 based on color
intensity of the red precipitate in immunoperoxidase study
with: 11 representing light; 21 moderate; and 31 intense
staining. Two renal pathologists reviewed the slides blindly
and there was ;90% concordance between them. The
distribution of each isoenzyme in glomerular cells, different
tubule segments, and renal arteries was noted.
RESULTS
Phospholipase C-b1 isoform
The anti-PLC-b1 polyclonal antibody identified a 150 kD
protein in rat glomeruli and proximal tubules by Western
blot (Fig. 1). Immunohistochemical studies confirmed the
presence of staining in epithelial cells and capillary loops of
glomeruli (11) (Fig. 2 A, C) and in proximal tubules (21)
(Fig. 2 A, B). There was prominent brush border staining
which exceeded the staining of the basolateral membrane
and cytoplasm using the polyclonal PLC-b1 antibody in all
three subsegments of the proximal tubule. This finding of
brush border staining was unique to the PLC-b1 isoform
antibody because other isoform antibodies did not detect
brush border staining. In addition, there was 11 immuno-
reactivity in DCTs (Fig. 2A) and 21 in medullary thick
ascending limbs (mTALs; Fig. 2D) and inner medullary
collecting ducts (IMCDs; data not shown). Interestingly,
cortical collecting ducts (CCDs; Fig. 2 A, D) and outer
medullary collecting ducts (OMCDs; data not shown)
exhibited the brightest staining (31). Large and small
arteries were negative, however, the vasa recta showed
intense staining of 31 (Fig. 2D). Table 1 summarizes the
PLC isoform expression.
Phospholipase C-g1 isoform
The anti-PLC-g1 antibody (both monoclonal and poly-
clonal) identified a 145 kD protein in rat PCTs, glomeruli,
CCDs, and mTALs by Western blot (Fig. 3). Immunohis-
tochemically, in the proximal tubule (S1, S2, and S3 sub-
segments), cytoplasmic staining was graded as 11, and
there was no brush border staining (data not shown). Distal
convoluted tubule and IMCD stained 11 as well (data not
shown). The most intensely staining part of the nephron
was the mTAL in the outer medullary region (21).
Large and small arteries also stained at an intensity of
21, specifically localized to the internal elastic lamina
membrane (Fig. 4). Interestingly, the PLC-g1 antibody was
the only one of the three isoform antibodies to stain renal
arteries. Vasa recta also showed 11 staining (data not
shown). Table 1 summarizes the PLC isoform expression.
Phospholipase C-d1 isoform
The anti-PLC-d1 monoclonal antibody reacted with an
85 kD protein from rat glomeruli, proximal tubules, CCDs,
Fig. 3. Expression of phospholipase C (PLC)-g1 in microdissected rat proximal convoluted tubule (PCT), cortical collecting duct (CCD), medullary
thick ascending limb (mTAL), and glomeruli. (A) Western analysis of protein from microdissected rat PCT and of sieved glomeruli (100 mg protein
loaded) identifies a 145 kD protein when probed with a monoclonal mouse antibody raised against bovine PLC- g1. (B) Protein (20 mg protein loaded)
from microdissected PCT, CCD, and mTAL also identify a 145 kD protein. Rat liver and brain were used as positive controls.
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and mTALs by Western blot (Fig. 5). Immunohistochemi-
cal studies confirmed the presence of PLC-d1 in all of the
above segments with the most prominent staining in
mTALs (31) (Fig. 6A). Also shown in Figure 6A is staining
of the thick descending limbs (S3) segment, which is
cytoplasmic and graded as 11. Of note, the brush border is
negative. The S1 and S2 proximal tubule staining was
graded as 11 with no brush border positivity observed as
well (data not shown). IMCDs did show intense, 2 to 31
staining that was more prominent along the basolateral
border of the epithelial cells (Fig. 6B). Large and small
arteries were unstained, and vasa recta were mildly and
focally positive (11). Table 1 contains a summary of
PLC-g1, -b1, and -d1 isoform expression identified by
Western blot and immunohistochemical analyses.
DISCUSSION
The major finding of this study is the variation in the
pattern of expression of the immunoreactive PLC isoforms
in rat glomeruli, nephron segments, and renal vasculature.
Our results show that multiple PLC isoforms are expressed
throughout the cortical and medullary regions of the kid-
ney, but with some segment-specific differences. Notably,
PLC-b1 is the only isoform detected in the brush border of
the proximal tubule and PLC-g1 is the only isoform de-
tected in large and small arteries. Vasa recta express
PLC-b1 and inner medullary collecting ducts express
PLC-d1 much more intensely and widespread than the
other isoforms. Although we are the first, to our knowl-
edge, to report PLC isoform expression in specific nephron
segments in vivo, others have shown that: (1) PLC-b1, -g1,
and -d1 are present in whole rat renal cortical membranes
and in both the outer and inner medulla of rat kidney [8,
15]; and (2) cultured rat glomerular mesangial cells pre-
dominately express the PLC-g and PLC-d isoforms with
less intense expression of the PLC-b isoforms [1].
The pattern of PLC isoforms we observed in glomeruli in
vivo are consistent with those identified in cultured rat
mesangial cells [1]. At least in the case of PLC, this
concordance suggests that the signal transduction pathways
activated in cultured glomerular mesangial cells may be
useful for studying signal transduction mechanisms present
in glomeruli in vivo. For example, the glomerulus has been
shown to involve PLC in angiotensin II-mediated responses
[1, 16] and in cultured glomerular mesangial cells, PLC
signaling events induced by angiotensin II appear to involve
both G protein coupled PLC-b isoform activation as well as
tyrosine phosphorylation of the PLC-g isoform [1, 16].
The thick ascending limb showed intense immunoreac-
tivity for each of the PLC isoforms. This finding is inter-
esting because the outer medulla has the greatest abun-
dance of mRNA coding for the IP3 receptor [17] and IP3 is
Fig. 4. Phospholipase C (PLC)-g1 in a rat kidney artery. Strong positiv-
ity of internal elastic lamina is shown (immunoreactivity, 1:100 rabbit
anti-rat polyclonal PLC-g1 antibody; 3400). Publication of this figure in
color was made possible by a grant from Hoechst Marion Roussel, Inc.
Fig. 6. PLC-d1 in outer stripe of outer medulla (A) and in inner medulla
(B). (A) Thick ascending limbs (m) show intense staining. Descending
thick loops of Henle (S3) are also positive but in less intensity and with
negative brush-border. (B) Positivity of collecting ducts of papilla, accen-
tuated on basolateral border of the cells (immunohistochemistry, 1:100
mouse anti-bovine monoclonal PLC-d1 antibody; A 3400, B 3400).
Publication of this figure in color was made possible by a grant from
Hoechst Marion Roussel, Inc.
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generated when PLC is activated. In addition, cultured
renal medullary interstitial cells produce IP3 in response to
angiotensin II [18].
Our finding that only the PLC-g1 isoform is expressed in
renal arteries is consistent with data obtained from cultured
rat aortic vascular smooth muscle cells (VSMC). In the
cultured cells there was no PLC-b isoform, suggesting that
signal transduction events coupled to PLC probably involve
PLC-g1, and not PLC-b coupled to a G protein as has been
classically described [1]. However, our studies showed
PLC-g1 staining only in the internal elastic lamina and not
in VSMC. In contrast to the results in arteries, the vasa
recta stained most intensely for the PLC-b1 isoform, while
less intense staining was observed with the PLC-g1 and
PLC-d1 antibodies.
Our findings show that in the proximal tubule in vivo, all
three families of PLC isoforms are expressed, suggesting
that multiple signaling events involving PLC may be occur-
ring in vivo. Since the brush border of the proximal tubule
expresses only the PLC-b1 isoform of all eight of the known
isoforms(unpublished observations), there may be only one
signaling pathway coupled to PLC in this tissue. Of note,
the type 1 angiotensin II receptors are present in both
apical and basolateral segments of the proximal tubule [19,
20], and when either is stimulated, there is an increase in
IP3 generation [21]. Specific regulatory mechanisms involv-
ing PLC isoforms in apical or basolateral membranes of the
proximal tubule have not been described, but angiotensin II
is known to have a biphasic effect on proximal tubule
sodium transport [22]. Our studies could provide some
insight into why this phenomenon occurs. For example,
different concentrations of angiotensin II could activate
different PLC isoforms in the proximal tubule.
In summary, these results are the first report of the
distribution of PLC isoforms expressed in individual
nephron segments of the rat kidney in vivo. The presence of
multiple PLC isoforms that are known to have distinct
regulatory mechanisms suggests that PLC may be involved
in important signaling pathways in response to different
hormones and growth factors affecting rat kidney function
in vivo. Specifically, if angiotensin II is coupled to PLC in
the brush border of the proximal tubule and renal vascula-
ture, then it is likely linked to the PLC-b isoform in the
former and to the PLC-g isoform in the latter. However,
more specific investigations need to be performed in order
to test this hypothesis. In addition, since PLC isoform
expression is similar in cultured mesangial cells and in
intact glomeruli in vivo, this cell culture model may be
useful for studying cell signal transduction mechanisms in
vivo. Our determination of PLC isoform expression in other
nephron segments may be useful in comparing results from
cell culture models of signal transduction mechanisms for
specific nephron segments. Finally, the use of these iso-
form-specific antibodies in various rat models of human
diseases may allow the detection in vivo of subtle changes in
PLC isoform expression that may occur as a specific disease
progresses, such as in hypertension.
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